New hope against deadly mold infections: generic drug shows promise
NCT ID NCT07239765
First seen Nov 20, 2025 · Last updated May 16, 2026 · Updated 21 times
Summary
This study tested a generic antifungal drug called ABCD in 67 adults with serious mold infections inside the body. The goal was to see if the drug is safe and works well. Patients received the drug for 2 to 6 weeks, and researchers tracked side effects and how many completed treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INVASIVE MOLD DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The First Affiliated Hospital Of Guangzhou Medical University
Guangzhou, China
Conditions
Explore the condition pages connected to this study.